Aurora Cannabis, Inc. ACB shares are trading higher on Thursday after the company announced it discovered a novel source of genetic resistance against powdery mildew, a pathogen, in cannabis sativa.

What To Know: Aurora's discovery will enable the company to develop powdery mildew-resistant plants, which Aurora is set to explore for commercial launch later this year.

Lana Culley, Vice President of Innovation and International Operations at Aurora, said, “This discovery offers a critical solution to a pressing challenge in the cannabis industry worldwide. At Aurora Coast, our state-of-the-art research and development facility, we continuously search for ways to add value to our proprietary cannabis cultivars, and this discovery will lead to new means of managing disease in cannabis production. This success story underscores the impact of our investment in scientific excellence, a commitment that sets Aurora apart from our competitors.”

See Also: Alphabet’s Waymo Receives Mapping Permit For San Francisco Airport In A Step Toward SFO Robotaxi Service

ACB Price Action: At the time of publication, Aurora shares are trading 9.56% higher at $4.75, according to data from Benzinga Pro.

Image: This illustration was generated using artificial intelligence via Midjourney.